The fact that assays are in the works suggests we may see a rise in anticipation of the results... This stock is undervalued. I personally enjoyed the ride to about 1.02-4 last spring and reentered in the summer.

Hopefully we will see a similar rise to the $1.00 range in the not too distant future.